Business ❯ Pharmaceuticals

Market Competition

Novo Nordisk Obesity Drugs Eli Lilly Obesity Treatments Industry Trends Bidding Wars Weight Loss Drugs Rivalry Job Cuts Workforce Management Mergers and Acquisitions Weight Loss Sales Performance Revenue Product Development GSK Market Dominance Johnson & Johnson Generic Drugs Biosimilars Industry Players Financial Performance Corporate Restructuring

Novo Nordisk Foundation Installs Lars Rebien Sørensen as Chair After Shareholder Vote

The foundation used its 77% voting power to cement control, intensifying governance concerns among minority investors.

Pfizer Closes Metsera Buyout, Adding GLP-1 Assets in Cash-Plus-CVR Deal

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

Pfizer Wins Early U.S. Antitrust Clearance for Metsera Deal as Novo’s Higher Bid Pressures Timeline

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet